Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
Sofetabart mipitecan is a novel folate receptor alpha (FR?) antibody-drug conjugate (ADC) leveraging proprietary linker technology and an exatecan payload to target tumor cells
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
Subscribe To Our Newsletter & Stay Updated
